ARCHIVES

Bristol-Myers Survey Predicts Year 2000 Survival of 66%

This article is from The Cancer Letter archive.

Vol. 13 No. 14 | April 3, 1987

Download PDF Visit The Full Archive

Related Articles

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

MD Anderson Expands Reach Into Florida, Ohio

September 26, 2014

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008

NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It

January 24, 1986

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977